HCA Healthcare profits rise as resilient admissions growth offsets cost pressures

HCA Healthcare (NYSE:HCA) posted a solid start to 2026, delivering a double-digit increase in earnings per share as steady patient volumes and operational "resiliency" initiatives helped the hospital giant navigate a complex reimbursement landscape.

The Nashville-based healthcare provider (NYSE:HCA) reported first-quarter revenue of $19.109 billion, a 4.3% increase compared to the $18.318 billion recorded in the same period last year.

Net income attributable to HCA Healthcare edged up slightly to $1.620 billion.

However, diluted earnings per share (EPS)—and diluted EPS as adjusted—surged 10.9% to $7.15, benefiting from the company’s aggressive share repurchase program.

Operational metrics remained positive, with same-facility admissions growing 0.9% and same-facility equivalent admissions increasing 1.3% year-over-year.

The growth comes as HCA continues to expand its network, which currently includes 189 hospitals and approximately 2,600 ambulatory sites of care.

Adjusted EBITDA for the quarter rose 1.9% to $3.802 billion, reflecting the company's ability to manage labor costs and inflationary pressures.

The company’s financial position was bolstered by a significant 22% jump in cash flows from operating activities, which reached $2.014 billion for the quarter.

This liquidity supported HCA's continued commitment to returning value to shareholders; the company paid a quarterly dividend of $0.78 per share on March 31 and remains active under its $10 billion share repurchase authorization announced earlier this year.

HCA also maintained its full-year 2026 guidance, which projects total revenues between $76.5 billion and $80 billion and diluted EPS in the range of $29.10 to $31.50.